Majid Sadeghizadeh
Overview
Explore the profile of Majid Sadeghizadeh including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
189
Citations
2183
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Abbasi H, Hosseinkhani F, Imani Fouladi B, Tarighi S, Sadeghizadeh M, Montazeri M
Iran J Pharm Res
. 2025 Jan;
23(1):e151714.
PMID: 39830662
Background: Mutations in the have been linked to the initiation and progression of breast cancer, as well as resistance to chemotherapy. Therefore, the development of novel treatment approaches is essential...
2.
Hashemabadi M, Sasan H, Hosseinkhani S, Amandadi M, Samareh Gholami A, Sadeghizadeh M
Commun Biol
. 2024 Oct;
7(1):1344.
PMID: 39420075
The CRISPR system finds extensive application in molecular biology, but its continuous activity can yield adverse effects. Leveraging programmable CRISPR/Cas9 function via nano-device mediation effectively mitigates these drawbacks. The integration...
3.
Beikzadeh B, Khani M, Zarinehzadeh Y, Abedini Bakhshmand E, Sadeghizadeh M, Rabbani S, et al.
PLoS One
. 2024 Oct;
19(10):e0311817.
PMID: 39388499
Cardiac fibrosis (c-fibrosis) is a critical factor in cardiovascular diseases, leading to impaired cardiac function and heart failure. This study aims to optimize the isoproterenol (ISO)-induced c-fibrosis model and evaluate...
4.
Vaseghi A, Sadeghizadeh M, Herb M, Grumme D, Demidov Y, Remmler T, et al.
ACS Appl Bio Mater
. 2024 Oct;
7(12):7917-7935.
PMID: 39360961
The aim of this study is to design a therapeutic enhanced three-dimensional (3D) silk fibroin (SF)-based scaffold containing propolis (Ps)-loaded chitosan (CH) nanocarriers. To this aim, we initially synthesized a...
5.
Inhibition of HIV-1 infection with curcumin conjugated PEG-citrate dendrimer; a new nano formulation
Ebrahimi S, Sadeghizadeh M, Aghasadeghi M, Shafiee Ardestani M, Amini S, Vahabpour R
BMC Complement Med Ther
. 2024 Oct;
24(1):350.
PMID: 39358802
Background: Nano-drug delivery systems have become a promising approach to overcoming problems such as low solubility and cellular uptake of drugs. Along with various delivery devices, dendrimers are widely used...
6.
Ashin Z, Sadeghi-Mohammadi S, Vaezi Z, Najafi F, AdibAmini S, Sadeghizadeh M, et al.
BMC Complement Med Ther
. 2024 Sep;
24(1):337.
PMID: 39304876
Background: Drug combination therapy is preferred over monotherapy in clinical research to improve therapeutic effects. Developing a new nanodelivery system for cancer drugs can reduce side effects and provide several...
7.
Vaseghi A, Parchin R, Chamanie K, Herb M, Maleki H, Sadeghizadeh M
BMC Complement Med Ther
. 2024 Apr;
24(1):165.
PMID: 38641781
In this study we develop novel type of antibacterial chitosan-propolis NPs to improve theantimicrobial activity against various pathogens. To this aim, we primarily extracted propolis with methylal and ethanol as...
8.
Safari Z, Sadeghizadeh M, Zavaran Hosseini A, Hazrati A, Soudi S
Biomed Pharmacother
. 2024 Mar;
173:116382.
PMID: 38460368
Lymphoid organs are the main structural components of the immune system. In the current research, the mixture of poly lactic-co-glycolic acid (PLGA), polycaprolactone (PCL), and M13 phage or its RGD-modified...
9.
Entezari M, Soltani B, Sadeghizadeh M
Sci Rep
. 2024 Feb;
14(1):4715.
PMID: 38413784
MicroRNA expression in breast cancer (BC) is explored both as a potential biomarker and for therapeutic purposes. Recent studies have revealed that miR-203a-3p is involved in BC, and importantly contributes...
10.
Dabiri H, Sadeghizadeh M, Ziaei V, Moghadasi Z, Maham A, Hajizadeh-Saffar E, et al.
Sci Rep
. 2024 Feb;
14(1):3689.
PMID: 38355744
In type 1 diabetes, the immune system destroys pancreatic beta cells in an autoimmune condition. To overcome this disease, a specific monoclonal antibody that binds to pancreatic beta cells could...